SummitTX Capital »

An2 Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.9M 598k 4.84

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Analog Devices (ADI)
MKS Instruments (MKSI)
Asml Hldg Nv N Y Registry Shs (ASML)
Warner Bros Discovery Com Ser A (WBD)
Applied Materials (AMAT)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Nxp Semiconductors N V (NXPI)
Amazon (AMZN)
O'reilly Automotive (ORLY)
Cbre Group Cl A (CBRE)
Electronic Arts (EA)
Micron Technology (MU)
3M Company (MMM)

View all positions for SummitTX Capital

Top funds holding An2 Therapeutics

Vivo Capital
Commodore Capital
Millennium Management
BlackRock
Spruce Street Capital
Almitas Capital
Vanguard Capital Management
Adage Capital Partners GP
Citadel Advisors
Boxer Capital Management
Geode Capital Management
SummitTX Capital
Balyasny Asset Management
Stonepine Capital Management
Ameriprise Financial

View all funds holding An2 Therapeutics